HLB Therapeutics Co.,Ltd. (KOSDAQ: 115450)
South Korea
· Delayed Price · Currency is KRW 8,040.00
-820.00 (-9.26%)
Oct 11, 2024, 2:48 PM KST
HLB Therapeutics Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | -0 | -0 | -0 | - | - | - | Upgrade
|
| Revenue | 60,298 | 53,749 | 42,403 | 43,586 | 42,930 | 58,966 | Upgrade
|
| Revenue Growth (YoY) | 21.75% | 26.76% | -2.72% | 1.53% | -27.20% | 35.29% | Upgrade
|
| Cost of Revenue | 52,096 | 46,459 | 33,682 | 38,579 | 36,464 | 53,595 | Upgrade
|
| Gross Profit | 8,202 | 7,290 | 8,721 | 5,007 | 6,466 | 5,372 | Upgrade
|
| Selling, General & Admin | 17,596 | 15,310 | 15,673 | 15,641 | 15,786 | 13,072 | Upgrade
|
| Other Operating Expenses | 300.42 | 185.18 | 273.11 | 240.04 | 218.66 | 350.28 | Upgrade
|
| Operating Expenses | 18,709 | 16,132 | 16,228 | 16,094 | 17,732 | 17,254 | Upgrade
|
| Operating Income | -10,507 | -8,842 | -7,507 | -11,087 | -11,267 | -11,883 | Upgrade
|
| Interest Expense | -1,659 | -1,113 | -5,146 | -1,160 | -4,254 | -1,874 | Upgrade
|
| Interest & Investment Income | 1,107 | 1,277 | 1,230 | 96.09 | 217.24 | 533.75 | Upgrade
|
| Earnings From Equity Investments | -1,167 | - | - | - | -909.06 | -1,316 | Upgrade
|
| Currency Exchange Gain (Loss) | 4,220 | 94.65 | 327.03 | 97.78 | -86.81 | 25.47 | Upgrade
|
| Other Non Operating Income (Expenses) | -2,955 | -3,365 | -1,334 | 15.88 | 5.87 | -132.92 | Upgrade
|
| EBT Excluding Unusual Items | -10,960 | -11,949 | -12,430 | -12,038 | -16,294 | -14,646 | Upgrade
|
| Gain (Loss) on Sale of Investments | -11,289 | 8,492 | 1,879 | -359.48 | 13.53 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 45.79 | 63.85 | -598.18 | -14.8 | 4.18 | -0.87 | Upgrade
|
| Asset Writedown | -5,795 | - | -424.08 | -4,632 | -1,953 | -2,085 | Upgrade
|
| Other Unusual Items | 624.11 | 624.11 | - | -720.83 | 829.12 | - | Upgrade
|
| Pretax Income | -27,374 | -2,769 | -11,573 | -17,764 | -17,401 | -16,732 | Upgrade
|
| Earnings From Continuing Operations | -27,374 | -2,769 | -11,573 | -17,764 | -17,401 | -16,732 | Upgrade
|
| Earnings From Discontinued Operations | -825.09 | -310.18 | -530.86 | - | - | -448.06 | Upgrade
|
| Net Income to Company | -28,199 | -3,079 | -12,104 | -17,764 | -17,401 | -17,180 | Upgrade
|
| Minority Interest in Earnings | 911.29 | 777.16 | 750.45 | 567.08 | 498.15 | 756.76 | Upgrade
|
| Net Income | -27,288 | -2,302 | -11,354 | -17,197 | -16,902 | -16,423 | Upgrade
|
| Net Income to Common | -27,288 | -2,302 | -11,354 | -17,197 | -16,902 | -16,423 | Upgrade
|
| Shares Outstanding (Basic) | 73 | 72 | 65 | 58 | 54 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 73 | 72 | 65 | 58 | 54 | 52 | Upgrade
|
| Shares Change (YoY) | 6.77% | 10.59% | 10.86% | 7.26% | 4.63% | 5.32% | Upgrade
|
| EPS (Basic) | -376.22 | -32.12 | -175.21 | -294.20 | -310.14 | -315.29 | Upgrade
|
| EPS (Diluted) | -376.22 | -32.13 | -175.21 | -294.20 | -310.14 | -315.29 | Upgrade
|
| Free Cash Flow | -2,985 | 3,025 | -12,204 | -12,091 | -11,736 | -6,099 | Upgrade
|
| Free Cash Flow Per Share | -41.15 | 42.21 | -188.33 | -206.84 | -215.35 | -117.08 | Upgrade
|
| Gross Margin | 13.60% | 13.56% | 20.57% | 11.49% | 15.06% | 9.11% | Upgrade
|
| Operating Margin | -17.42% | -16.45% | -17.70% | -25.44% | -26.24% | -20.15% | Upgrade
|
| Profit Margin | -45.25% | -4.28% | -26.78% | -39.46% | -39.37% | -27.85% | Upgrade
|
| Free Cash Flow Margin | -4.95% | 5.63% | -28.78% | -27.74% | -27.34% | -10.34% | Upgrade
|
| EBITDA | -2,196 | -363.14 | -5,841 | -9,386 | -10,566 | -11,194 | Upgrade
|
| EBITDA Margin | -3.64% | -0.68% | -13.77% | -21.54% | -24.61% | -18.98% | Upgrade
|
| D&A For EBITDA | 8,311 | 8,479 | 1,666 | 1,701 | 700.54 | 688.3 | Upgrade
|
| EBIT | -10,507 | -8,842 | -7,507 | -11,087 | -11,267 | -11,883 | Upgrade
|
| EBIT Margin | -17.42% | -16.45% | -17.70% | -25.44% | -26.24% | -20.15% | Upgrade
|
| Advertising Expenses | - | - | 0.21 | 7.07 | 32.42 | 6.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.